Therefore, the present study reveals a new role of meningeal lymphatics in treating brain tumors by RT and RT-triggered anti-tumor immunity and suggests the potential of VEGF-C mRNA in combination therapies with RT for brain tumors. Here, VEGFC is linked to brain neoplasm.